AYTU BIOPHARMA, INC Annual Net Cash Provided by (Used in) Investing Activities in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Aytu Biopharma, Inc annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2017 to 2024.
  • Aytu Biopharma, Inc Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2023 was -$76K, a 281% decline year-over-year.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$329K, a 181% decline from 2023.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$117K, a 96.4% increase from 2022.
  • Aytu Biopharma, Inc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$3.25M, a 16.8% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$329K -$212K -181% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 -$117K +$3.13M +96.4% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 -$3.25M -$466K -16.8% Jul 1, 2021 Jun 30, 2022 10-K 2023-10-12
2021 -$2.78M +$2.87M +50.8% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 -$5.66M -$4.59M -433% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
2019 -$1.06M -$578K -119% Jul 1, 2018 Jun 30, 2019 10-K 2020-10-06
2018 -$484K +$3.05M +86.3% Jul 1, 2017 Jun 30, 2018 10-K 2019-09-26
2017 -$3.53M Jul 1, 2016 Jun 30, 2017 10-K 2018-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.